First IBS pain-relief device hits market
June 18, 2019
The first FDA-approved device to reduce functional abdominal pain in younger patients with irritable bowel syndrome is now available to medical providers.
Recent Content
Top 6 Cancer Drug Trends
June 17, 2019
A record number of new oncology treatments launched in the US last year and spending on cancer drugs soared. Here are the top 6 cancer drug trends revealed in the report.
FDA okays cluster headache drug
June 11, 2019
FDA cleared the first-and-only calcitonin gene-related peptide (CGRP) antibody for cluster headaches.
Self-injectable respiratory medication opens doors for patients with severe asthma
June 10, 2019
The first respiratory biologic to be approved for administration via an autoinjector will be available in the US soon.
Revolutionary smartphone device could offer migraine sufferers hope
June 3, 2019
FDA granted market authorization for a non-invasive, smartphone device that offers respite from migraines.
FDA clears novel breast cancer drug
June 3, 2019
FDA cleared alpelisib (Piqray), the first PI3K inhibitor to treat breast cancer, to be used in combination with fulvestrant (Faslodex).
Express Scripts to launch first digital health formulary
May 21, 2019
Express Scripts, a Cigna company, plans to launch the industry's first stand-alone digital health formulary.
Top 3 new drug approvals
May 20, 2019
FDA approved some important new therapies, including the first anticoagulant for children, an injectable for diabetic retinopathy, and a treatment for renal cell carcinoma.
US accuses generic drug makers of price collusion
May 14, 2019
Generic drug makers are defending their practices after 44 US states accused Teva Pharmaceuticals and other pharma makers of conspiring to inflate their prices in a lawsuit.
Drug prices in ads run risk of confusing patients
May 13, 2019
A new government rule requiring pharma makers to disclose drug prices in television ads will likely create more confusion for consumers, analysts and organizations said.
